MARKET

AORT

AORT

Artivion, Inc.
NYSE
27.48
+0.02
+0.07%
After Hours: 28.13 +0.65 +2.37% 18:12 07/26 EDT
OPEN
27.82
PREV CLOSE
27.46
HIGH
28.03
LOW
27.16
VOLUME
151.63K
TURNOVER
0
52 WEEK HIGH
29.24
52 WEEK LOW
12.16
MARKET CAP
1.15B
P/E (TTM)
-105.1262
1D
5D
1M
3M
1Y
5Y
1D
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results
Artivion's second quarter 2024 financial results will be released on August 8, 2024 after the market closes. The Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results. Artivion is a leading cardiac and vascular surgery company focused on aortic disease.
PR Newswire · 1d ago
Next Century Growth Investors Q2 2024 Commentary
Seeking Alpha · 3d ago
Weekly Report: what happened at AORT last week (0715-0719)?
Weekly Report · 4d ago
Weekly Report: what happened at AORT last week (0708-0712)?
Weekly Report · 07/15 09:20
Weekly Report: what happened at AORT last week (0701-0705)?
Weekly Report · 07/08 09:21
A Glimpse Into The Expert Outlook On Artivion Through 4 Analysts
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company has an average 12-month price target of $27.5. 4 analysts provided ratings for Artivion in the latest quarter. The company boasts an average revenue growth rate of 17.06% over the past five years.
Benzinga · 07/02 16:01
Artivion Price Target Raised to $30.00/Share From $28.00 by Lake Street
Dow Jones · 07/02 14:20
Artivion Is Maintained at Buy by Lake Street
Dow Jones · 07/02 14:20
More
About AORT
Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.

Webull offers Artivion Inc stock information, including NYSE: AORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AORT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AORT stock methods without spending real money on the virtual paper trading platform.